We are pleased to share that Geoffrey S. Ginsburg, M.D., Ph.D., Founder and Co-Chair of G2MC, will be presented with the 17th Annual Award for Leadership in Personalized Medicine during the Personalized Medicine Coalition (PMC) Personalized Medicine and the Patient summit on November 15, 2022.
Dr. Ginsburg is the Chief Medical and Scientific Officer of the All of Us Research Program at the U.S. National Institutes of Health. He leads the Division of Medical and Scientific Research and is responsible for helping to set the scientific vision and strategy for the program. Prior to joining All of Us, Dr. Ginsburg was the Founding Director of the Center for Applied Genomics & Precision Medicine in the Duke University School of Medicine, where he pioneered translational genomics and the development of novel diagnostics. In 2016, Dr. Ginsburg founded the Global Genomic Medicine Collaborative (G2MC) with the goal of enabling the implementation of genomic medicine worldwide.
After accepting the Personalized Medicine Coalition’s 17th Annual Award for Leadership in Personalized Medicine during the PMC summit, Dr. Ginsburg will share his views on the future of personalized medicine and patient care.
Continue reading to learn more about Dr. Ginsburg’s revolutionary work that has led to him being the deserving recipient of this award.
